Anthem Biosciences: Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI LODR Regulations)

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2025 we hereby inform that the Company has executed on February 23 2026 First amendment to the Loan agreement dated April 15 2024 entered with Neoanthem Lifesciences Private Limited (Wholly Owned Subsidiary).